Effect of the technique for assisting renal blood circulation on ischemic kidney in acute cardiorenal syndrome

Journal of Artificial Organs

Volumn 15, Issue 2, 2012, Pages 140-145

  Hanada, Shigeru ^a   Takewa, Yoshiaki ^a   Mizuno, Toshihide ^a   Tsukiya, Tomonori ^a   Taenaka, Yoshiyuki ^a   Tatsumi, Eisuke ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Cardiorenal syndrome; Extracorporeal circulation; Renal blood flow; Renal selective blood perfusion

Indexed keywords

CREATININE; OXYGEN; PROSTAGLANDIN E1; SODIUM; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTERY BLOOD FLOW; ARTICLE; CARDIORENAL SYNDROME; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE MODEL; EXTRACORPOREAL CIRCULATION; GOAT; HEART VENTRICLE PACING; KIDNEY BLOOD FLOW; KIDNEY ISCHEMIA; KIDNEY VASCULAR RESISTANCE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RENAL ARTERY; RENAL SELECTIVE BLOOD PERFUSION; URINARY EXCRETION;

ALPROSTADIL; ANIMALS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CARDIO-RENAL SYNDROME; GOATS; ISCHEMIA; KIDNEY; OXYGEN CONSUMPTION; RENAL CIRCULATION; VASCULAR RESISTANCE;

EID: 84864655059     PISSN: 14347229     EISSN: 16190904     Source Type: Journal    
DOI: 10.1007/s10047-011-0613-5     Document Type: Article

References (19)

1. Meyns B, Stolinski J, Leunens V, Verbeken E, Flameng W. Left ventricular support by catheter-mounted axial flow pump reduces infarct size. J Am Coll Cardiol. 2003;41:1087-95. (Pubitemid 36384893)
2. Reitan O, Steen S, Ohlin H. Hemodynamic effects of a new percutaneous circulatory support device in a left ventricular failure model. ASAIO J. 2003;49:731-6. (Pubitemid 37429677)
3. Konstam MA, Czerska B, Böhm M, Oren RM, Sadowski J, Khanal S, Abraham WT, Wasler A, Dahm JB, Gavazzi A, Gradinac S, Legrand V, Mohacsi P, Poelzl G, Radovancevic B, Van Bakel AB, Zile MR, Cabuay B, Bartus K, Jansen P. Continuous aortic flow augmentation: A pilot study of hemodynamic and renal responses to a novel percutaneous intervention in decompensated heart failure. Circulation. 2005;112:3107-14.
4. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52:1527-39.
5. Rea ME, Dunlap ME. Renal hemodynamics in heart failure: Implications for treatment. Curr Opin Nephrol Hypertens. 2008;17:87-92. (Pubitemid 350295203)
6. Anand IS, Chugh SS. Mechanisms and management of renal dysfunction in heart failure. Curr Opin Cardiol. 1997;12:251-8. (Pubitemid 27252532)
7. Metra M, Nodari S, Parrinello G, Bordonali T, Bugatti S, Danesi R, Fontanella B, Lombardi C, Milani P, Verzura G, Cotter G, Dittrich H, Massie BM, Dei Cas L. Worsening renal function in patients hospitalised for acute heart failure: Clinical implications and prognostic significance. Eur J Heart Fail. 2008;10:188-95. (Pubitemid 351221392)
8. de Silva R, Nikitin NP, Witte KK, Rigby AS, Goode K, Bhandari S, Clark AL, Cleland JG. Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: Contributing factors and relationship to prognosis. Eur Heart J. 2006;27:569-81.
9. Kiil F, Aukland K, Refsum HE. Renal sodium transport and oxygen consumption. Am J Physiol. 1961;201:511-6.
10. Kurnik BR, Weisberg LS, Kurnik PB. Renal and systemic oxygen consumption in patients with normal and abnormal renal function. J Am Soc Nephrol. 1992;2:1617-26.
11. Mehta RL, Pascual MT, Soroko S, Chertow GM, PICARD Study Group. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA. 2002;288:2547-53. (Pubitemid 35386889)
12. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
13. Costanzo MR, Guglin ME, Saltzberg MT, Jessup ML, Bart BA, Teerlink JR, Jaski BE, Fang JC, Feller ED, Haas GJ, Anderson AS, Schollmeyer MP, Sobotka PA, UNLOAD Trial Investigators. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol. 2007;49:675-83. (Pubitemid 46205043)
14. Arbid EJ, Hakaim AG, LaMorte WW, Menzoian JO. Prevention of renal cortical ischemia during aortic clamping with prostaglandin E1. Arch Surg. 1995;130:326-30 (discussion 330-1).
15. Mahmoud IM, Hussein Ael-A, Sarhan ME, Awad AA, El Desoky I. Role of combined L-arginine and prostaglandin E1 in renal ischemia-reperfusion injury. Nephron Physiol. 2007;105:57-65. (Pubitemid 46496821)
16. Wilkens JH, Wilkens H, Elger B, et al. Cardiac and microcirculatory effects of different doses of prostaglandin E1 in man. Eur J Clin Pharmacol. 1987;33:133-7. (Pubitemid 17149224)
17. Brecht T, Ayaz M. Circulation parameters during intravenous and intra-arterial administration of increasing doses of prostaglandin E1 in healthy subjects. Klin Wochenschr. 1985;63:1201-4. (Pubitemid 16169742)
18. Lum GM, Aisenbrey GA, Dunn MJ, Berl T, Schrier RW, McDonald KM. In vivo effect of indomethacin to potentiate the renal medullary cyclic AMP response to vasopressin. J Clin Invest. 1977;59:8-13. (Pubitemid 8018034)
19. Grantham JJ, Orloff J. Effect of prostaglandin E1 on the permeability response of the isolated collecting tubule to vasopressin, adenosine 30,50-monophosphate, and theophylline. J Clin Invest. 1968;47:1154-61.